B-Right AI Platform

AI-powered ultrasound - supporting exam completeness and expert level fetal heart assessments.

Developed by: BrightHeart
FDA cleared

Save time. Ensure exam completeness. Deliver expert-level screening.

BrightHeart's standalone AI platform integrates seamlessly into any existing workflow as a plug and play solution that’s 100% compatible with your existing setup. Delivering AI guidance at every step of the prenatal ultrasound exam for precise tracking of the full anatomy, efficient evaluations, and expert-level fetal heart screening.

B-Right Views Completion Tracker: Automated Tracking. Total Confidence
- AI-powered live scan tracking of exam completeness
- Clear, moment-to-moment insights on exam progress throughout the scan

B-Right Views Fetal Heart: Comprehensive Views. Complete Scans.
- AI-guidance to confirm every critical fetal heart view
- 47% reduction in the rate of incomplete fetal heart scans in clinical practice, supporting lower rescan rates and a better patient experience

B-Right Screen: Expert-Level Fetal Heart Evaluation for CHD Screening.
- The ultimate screening tool delivering AI-powered analysis of 8 key structural markers to quickly identify or confidently rule out signs of severe CHD
- 98.7% sensitivity for detecting severe CHD indicators and 97.7% specificity in confirming normality among conclusive cases- supporting clear, confident decisions, and better care

About BrightHeart

BrightHeart is on a mission to deliver expert level ultrasound care worldwide - regardless of resources, setting, or expertise. BrightHeart’s B-Right AI Platform supports clinicians and sonographers - facilitating comprehensive and standardized expert level assessments during routine anatomy scans.

Expert Reviews

By providing real-time alerts, B-Right Views Fetal Heart helps sonographers to identify and correct missing views during the exam, reducing the need for repeat scans while potentially boosting sonographer confidence and facilitating earlier triage of high-risk cases.

DR. NATHAN FOX

Clinical Professor of OBGYN and MFM, Mount Sinai Partner, Carnegie Imaging for Women, NYC

 

Details

 
This software is compatible with all Voluson systems.
Products mentioned in the material may be subject to government regulations and may not be available in all countries. Shipment and effective sale can only occur after approval from the regulator. Please check with local GE HealthCare representative for details.
No disruption. No complexity. Just quiet, powerful support that integrates naturally into existing ultrasound workflows.

BrightHeart’s cloud-based platform can be quickly deployed at your center with a simple DICOM router installation step. From there, tablet installation at your center takes less than 5 minutes, enabling powerful BrightHeart AI support from first view to final review.
BrightHeart’s field team is here to support you every step of the way, supporting your efficiency to deliver the best care to your patients.
BrightHeart offers a discounted trial period with special terms exclusive to Voluson customers. It’s quick to install and easy to get started with no changes to your workflow or equipment. Reach out to book a demo and learn more about getting started.
Access to the Privacy Policy and Terms can be found here.

B-Right AI Platform: B-Right Views and B-Right Screen are FDA-cleared Class II medical devices. See the instructions for use for more information.

1. “Use of Artificial Intelligence–Based Software to Aid in the Identification of Ultrasound Findings Associated With Fetal Congenital Heart Defects” from Lam et al, Obstetrics & Gynecology, 2025.
2. “Optimizing screening for severe congenital heart defects on prenatal ultrasound using eight suspicious findings and artificial intelligence” from Rebarber et al., ISUOG abstract, 2025.
3. Critical fetal heart views as recommended by AIUM guidelines.
4. “Enhancing Ultrasound Standard View Completion in Fetal Heart Screening with an AI Software” from Lam et al, ISUOG abstract, 2025.
5. “Artificial Intelligence Accurately Detects Fetal Ultrasound Findings Suspicious For Major Congenital Heart Defects” from Zelop et al., Obstetrics & Gynecology, 2025.
Disclaimer
The products and services displayed on our platform are provided by independent third parties. GE HealthCare does not own, operate, or control products displayed on the Voluson™ Solution Store and is not responsible for their content, accuracy, performance, or compliance with applicable laws. GE HealthCare does not assume responsibility for product information or customer insights related to product. The inclusion of third-party products or services on our platform is for informational purposes only. It does not constitute an endorsement, guarantee, or warranty of any kind—express or implied—by GE HealthCare. GE HealthCare processes personal data in accordance with applicable data protection laws. By requesting product details, you consent to GE HealthCare collecting and sharing your personal information (such as name, email, company, and job title) with that third party to fulfil your request.

JB36535XX